✦ LIBER ✦

Phase II evaluation of the efficacy and safety of trastuzumab plus pertuzumab therapy in patients with HER2-positive metastatic breast cancer that had progressed during trastuzumab treatment

✍ Scribed by J. Cortes; K. Gelmon; P. Fumoleau; A. Wardley; S. Verma; P.F. Conte; L. Gianni; S.J. Kirk; V. McNally; J. Baselga

Book ID: 119598373
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 58 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)70882-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase Ib Study of Buparlisib plus Trastu

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

✍ Saura, C.; Bendell, J.; Jerusalem, G.; Su, S.; Ru, Q.; De Buck, S.; Mills, D.; R 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 898 KB

Efficacy and safety of trastuzumab plus

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

✍ Tomo Osako; Yoshinori Ito; Shunji Takahashi; Nahomi Tokudome; Takuji Iwase; Kiyo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 293 KB

Phase II Trial of Gemcitabine/Carboplati

Phase II Trial of Gemcitabine/Carboplatin (plus Trastuzumab in HER2-Positive Disease) in Patients with Metastatic Breast Cancer

✍ David Loesch; Lina Asmar; Kristi McIntyre; Lisa Doane; Michael Monticelli; Devch 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 132 KB

194 A Phase II Study of Trastuzumab Plus

194 A Phase II Study of Trastuzumab Plus Capecitabine with or Without Pertuzumab for HER2-positive Metastatic Breast Cancer as Second-line Treatment (PHEREXA)

✍ A. Urruticoechea; P. Canney; R. Separovic; T. Bachelot; J. Efran; J.L. Canon; P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase 2 study of everolimus combined w

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

✍ Hurvitz, Sara A.; Dalenc, Florence; Campone, Mario; OâRegan, Ruth M.; Tjan-Hei 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 327 KB

A Phase II Study of Weekly Vinorelbine a

A Phase II Study of Weekly Vinorelbine and Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer

✍ Juan Lucas Bayo-Calero; José I. Mayordomo; Pedro Sánchez-Rovira; Ramón Pérez-Car 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 97 KB